Sphera Funds Management Ltd. Achilles Therapeutics PLC Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.22 - $8.86 $1.02 Million - $2.15 Million	-242,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.81 - $9.93 $288,722 - $493,461	-49,694 Reduced 17.01%	242,500 $1.89 Million
Q2 2021 Aug 17, 2021	SELL	$9.79 - $17.86 $76,420 - $139,415	-7,806 Reduced 2.6%	292,194 $2.86 Million
Q1 2021 May 17, 2021	BUY	$16.55 - $16.55 $4.97 Million - $4.97 Million	300,000 New	300,000 $4.97 Million

24.3M

Ticker ACHL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,774,000
Market Cap $47.3M
Description
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.